Historical record - last NADAC publication: 6/1/2016
Product Information
TASIGNA 200 MG CAPSULE is a brand product labeled by Novartis Pharmaceuticals Corporation, priced at $94.1452 per EA under NDC 00078052687. Its NADAC has been published 34 times since Dec 23, 2015.
Strength
200 mg/1
Manufacturer
Novartis Pharmaceuticals CorporationNDC
00078052687
Classification
Brand
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/1/2016
Active Ingredients
NILOTINIB HYDROCHLORIDE MONOHYDRATEApproval Type
New Drug (NDA)
FDA Application
NDA022068On Market Since
10/29/2007
Pharmacological Classes
Price Statistics
The NADAC for TASIGNA 200 MG CAPSULE has been published 34 times since Dec 23, 2015, and over the history we have for it it has risen 9.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $94.1452 per EA |
|---|---|
| All-time high | $94.1452 (Aug 10, 2016) |
| All-time low | $86.3416 (Dec 23, 2015) |
| Median price | $92.2992 |
| Average price | $92.3164 |
| Largest weekly change | +6.9% (Jan 13, 2016) |
| Weeks tracked | 34 |
| Tracking since | Dec 23, 2015 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of TASIGNA 200 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for TASIGNA 200 MG CAPSULE, manufactured by Novartis Pharmaceuticals Corporation, is $94.1452 per EA (NDC 00078052687), effective Aug 10, 2016.
How has the price of TASIGNA 200 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for TASIGNA 200 MG CAPSULE has risen 9.0%. It has been tracked across 34 weekly CMS publications since Dec 23, 2015.
What are the highest and lowest recorded NADAC prices for TASIGNA 200 MG CAPSULE?
Since Dec 23, 2015, the NADAC for TASIGNA 200 MG CAPSULE has ranged from a low of $86.3416 (Dec 23, 2015) to a high of $94.1452 (Aug 10, 2016), with a median of $92.2992 per EA.
Are there cheaper alternatives to TASIGNA 200 MG CAPSULE?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as TASIGNA 200 MG CAPSULE, but none are currently priced below it.
Who manufactures TASIGNA 200 MG CAPSULE?
TASIGNA 200 MG CAPSULE (NDC 00078052687) is labeled by Novartis Pharmaceuticals Corporation, and CMS classifies it as a brand product.
Related Drugs
Same classification